Jennifer Osborne, APRN
Payments from drug & device makers
Across 505 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Amgen$1K
- Boehringer Ingelheim$1K
- Actelion Pharmaceuticals US, Inc.$802
- Novartis$670
- E.r. Squibb & Sons, L.L.C.$604
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 118 | $1,676 |
| Amgen | 55 | $1,338 |
| Boehringer Ingelheim | 63 | $1,032 |
| Actelion Pharmaceuticals US, Inc. | 53 | $802 |
| Novartis | 33 | $670 |
| E.r. Squibb & Sons, L.L.C. | 36 | $604 |
| Johnson & Johnson | 34 | $518 |
| Merck | 24 | $462 |
| Bayer | 15 | $256 |
| Boston Scientific | 7 | $214 |
| AstraZeneca | 14 | $192 |
| Abbott | 2 | $178 |
| Lexicon Pharmaceuticals, Inc. | 3 | $161 |
| Cormedix Inc. | 1 | $125 |
| Novo Nordisk | 4 | $115 |
| Amarin Pharma, Inc. | 6 | $107 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $104 |
| Esperion Therapeutics, Inc. | 6 | $93 |
| Chiesi USA, Inc. | 4 | $89 |
| Heartflow, Inc. | 3 | $62 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| AbbVie | 1 | $50 |
| Bridgebio Pharma, Inc. | 2 | $44 |
| United Therapeutics Corporation | 2 | $39 |
| Scpharmaceuticals Inc. | 2 | $38 |
| Exeltis, USA Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Philips North America LLC | 1 | $24 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $22 |
| Abiomed | 1 | $20 |
| Sanofi | 1 | $16 |
How this compares
$9,210 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Orem
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Stephanie GodfreyLindon$358K
- Mary SteinbackSalt Lake City$189K
- Shannon FordSouth Jordan$186K
- Jennalyn MayeuxSalt Lake City$151K
- Brett RawlinsKaysville$149K
- Shelby MillerSandy$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.